EIF2D Antikörper (Center)
Kurzübersicht für EIF2D Antikörper (Center) (ABIN7838066)
Target
Alle EIF2D Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Center
-
Verwendungszweck
- Rabbit polyclonal antibody to EIF2D
-
Spezifität
- Recognizes endogenous levels of EIF2D protein
-
Aufreinigung
- The antibody was purified by immunogen affinity chromatography.
-
Immunogen
- KLH-conjugated synthetic peptide encompassing a sequence within the center region of human EIF2D. The exact sequence is proprietary.
-
-
-
-
Applikationshinweise
- WB (1/500 - 1/1000)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Liquid in 0.42 % Potassium phosphate, 0.87 % Sodium chloride, pH 7.3, 30 % glycerol, and 0.01 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
-
-
- EIF2D (Eukaryotic Translation Initiation Factor 2D (EIF2D))
-
Andere Bezeichnung
- EIF2D
-
Hintergrund
- HCA56, LGTN, Eukaryotic translation initiation factor 2D, eIF2d, Hepatocellular carcinoma-associated antigen 56, Ligatin
-
Gen-ID
- 1939, 16865, 498225
-
UniProt
- P41214
Target
-